喻长远
学术任职：中国中医药学会、北京市实验动物学会等委员
研究领域：生命组学与大数据解读、中医药系统生物学研究、生态环境与大健康研究
科研项目
(1) 国家自然科学基金委员会, 面上项目, 82174531, 化湿解表法对病毒侵染过程的分子靶点可视化研究, 2022-01-01 至 2025-12-31, 55万元, 在研, 主持
(2) 科技部, 重点研发计划, 2019YFC1200104, -, 2019-12 至 2022-12, 510万元, 主持
(3) 科技部, 重大专项, 2019ZX09721001-007, 重大新药创制－耐药菌防治药物品种及 共性关键技术研发, 2019-01 至 2021-06, 200万元, 结题, 主持
代表性学术成果
代表性著作：
1.Engineering High-Robustness DNA Molecular Circuits by Utilizing Nucleases, Nanoscale, 2020, DOI: 10.1039/C9NR09979D.
2.Probing DNA Hybridization Equilibrium by Cationic Conjugated Polymer for Highly Selective Detection and Imaging of Single-Nucleotide Mutation, Analytical Chemistry, 2018, 90, 6804-6810.
3.Telomerase Activity Detection with Amplification-Free Single Molecule Stochastic Binding Assay, Analytical Chemistry, 2017, 89, 3576-3582.
4.Discrimination Cascade Enabled Selective Detection of Single Nucleotide Mutation, ACS Sensors, 2017, 2, 419-425.
5.A dynamic sandwich assay on magnetic beads for selective detection of single-nucleotide mutations at room temperature, Biosensors & Bioelectronics, 2017, 94, 305-311.
6.Metabolic Profile Changes of CCl4-Liver Fibrosis and Inhibitory Effects of Jiaqi Ganxian Granule[J]. Molecules. 2016, 21(6), 698.
7.Classification Models of HCV NS3 Protease Inhibitors Based on Support Vector Machine (SVM)，Combinatorial Chemistry & High Throughput Screening, 2015, 18(1), 24-32.
8.QSAR Studies on the Bioactivity of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase Inhibitors, Letters in Drug Design & Discovery, 2015, 12(9), 728-735.
9.Classification of Mixtures of Chinese Herbal Medicines Based on a Self-Organizing Map (SOM), Molecular Informatics, 2016, 35(3-4), 109-115.
10.Using support vector machine (SVM) for classification of selectivity of H1N1 neuraminidase inhibitors, Molecular Informatics, 2016, 35(3-4), 116-124.
专利：
1. 喻长远，杨昭，王璐瑶，白素杭，沈宗毅。膀胱癌耗竭型NKT细胞亚群、其特征基因及其应用。（专利申请号：202010669877.5）
2. 杨昭，王璐瑶，喻长远，白素杭，沈宗毅。膀胱癌耗竭型T细胞亚群、其特征基因及其应用。（专利申请号：202010627617 .1）
3. 喻长远，邱松，杨昭，国震宇，许立达，孙晓明，孙浩然，陈天童。一种超亲气电极提高微生物燃料电池产电量的工艺。（专利申请号：202010641473 .5）
4. 喻长远，杨昭，阎秋韵，沈宗毅，张富涵，张琨，钟博，白素杭，魏振华。一种CRISPR/Cas12a基因编辑系统及其应用。（专利申请号：201811588275.6）